AZD5305 hADME in Patients With Advanced Solid Malignancies

Clinical trial NCT06713369 · RECRUITING

Trial details

NCT number: NCT06713369
Sponsor: AstraZeneca
Status: RECRUITING
Phase: Phase 1
Study type: INTERVENTIONAL

Locally Advanced or Metastatic Solid Tumor

Start date: 2025-04-02
Primary completion: 2026-10-02
Enrollment: 8

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.